San Giuseppe Moscati Hospital
14
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.1%
1 terminated/withdrawn out of 14 trials
90.0%
+3.5% vs industry average
29%
4 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.
Role: collaborator
Evaluation of the Effects of Bicarbonate-calcium Water in Premenopausal and Postmenopausal Women as a Prevention of Osteoporosis
Role: collaborator
Aggressive Weight Loss Program in Chronic Plaque Psoriasis
Role: lead
Transanal Inspection and Management of Low ColoRectal Anastomosis Performed With a New Technique
Role: collaborator
Pre-operative Very Low-calorie Protein-based Versus Hypocaloric Enteral Nutrition
Role: lead
Demonstrate the Effectiveness to Hemopatch in Controlling Postoperative Bleeding After Laparoscopic Cholecistectomy and in Reducing of Morbidity and Postoperative Hospital Stay
Role: collaborator
Italian Absorb Registry
Role: collaborator
TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer
Role: collaborator
Early Precut in Difficult Biliary Cannulation
Role: collaborator
Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction
Role: lead
VLCD by Enteral Route for Weight Loss
Role: lead
Everolimus Stent in Myocardial Infarction
Role: lead
Everolimus Stent in Patients With Coronary Artery Disease (CAD)
Role: lead
Drug Eluting Stent (DES) in Primary Angioplasty
Role: lead
All 14 trials loaded